Cargando…
Acting on sex and gender in medical innovation is good for business
Lavanya Vijayasingham and colleagues argue that as well as improving safety and efficacy, considering sex and gender related factors in medical research can have commercial benefits
Autores principales: | Vijayasingham, Lavanya, Bischof, Evelyne, Ateghang-Awankem, Bernadette, Rumaney, Maryam, Otmani del Barrio, Mariam, Cheah, Phaik Yeong, ter-Meulen, Ajoke Sobanjo, Tannenbaum, Cara, Morgan, Rosemary, Wolfe, Jeannette |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group Ltd.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10242613/ https://www.ncbi.nlm.nih.gov/pubmed/37286208 http://dx.doi.org/10.1136/bmj-2022-072242 |
Ejemplares similares
-
Sex-disaggregated data in COVID-19 vaccine trials
por: Vijayasingham, Lavanya, et al.
Publicado: (2021) -
Evaluating the cost-effectiveness of maternal pertussis immunization in low- and middle-income countries: A review of lessons learnt
por: Russell, Louise B., et al.
Publicado: (2021) -
Making pharmaceutical research and regulation work for women
por: Ravindran, TK Sundari, et al.
Publicado: (2020) -
Every Country, Every Family: Time to Act for Group B Streptococcal Disease Worldwide
por: Lawn, Joy E, et al.
Publicado: (2021) -
Closer and closer? Maternal immunization: current promise, future horizons
por: Engmann, Cyril, et al.
Publicado: (2020)